Moderna, Inc.
(NASDAQ : MRNA)

( )
MRNA After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
REGNRegeneron Pharmaceuticals, Inc. 0.58%575.732.7%$668.74m
AMGNAmgen, Inc. -0.43%227.981.3%$584.64m
ILMNIllumina, Inc. 2.54%325.923.5%$569.57m
ARRYArray BioPharma Inc. 11.69%43.9414.2%$534.29m
GILDGilead Sciences, Inc. 0.76%60.671.0%$505.18m
MRNAModerna, Inc. 3.61%70.840.0%$488.77m
VRTXVertex Pharmaceuticals, Inc. -0.62%210.081.9%$485.35m
IMMUImmunomedics, Inc. 0.05%87.8611.0%$373.44m
NVAXNovavax, Inc. 2.67%93.5996.5%$310.87m
ALXNAlexion Pharmaceuticals, Inc. 1.25%119.672.0%$283.93m
BIIBBiogen, Inc. -0.79%266.801.6%$262.52m
EXASEXACT Sciences Corp. 7.51%107.0920.7%$236.03m
BNTXBioNTech SE -1.55%86.360.0%$211.34m
SRNESorrento Therapeutics, Inc. 5.48%8.281.4%$191.26m
SGENSeagen Inc. 1.49%200.666.0%$164.79m

Company Profile

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.